98%
921
2 minutes
20
The improved magnetically insulated transmission line oscillator (MILO) is a gigawatt-class L-band high power microwave tube. It has allowed us to generate 3.1 GW pulse of 40 ns duration in the single-pulse operation and 500 MW pulse of 25 ns duration in the repetition rate operation. However, because of the severe impedance mismatch, the power conversion efficiency is only about 4% in the repetition rate operation. In order to eliminate the impedance mismatch and obtain repetitive long-pulse high-power microwave (HPM), a series of experiments are carried out and the recent progress is presented in this paper. In the single-pulse operation, when the diode voltage is 466 kV and current is 41.6 kA, the radiated microwave power is above 2.2 GW, the pulse duration is above 102 ns, the microwave frequency is about 1.74 GHz, and the power conversion efficiency is about 11.5%. In the repetition rate operation, under the condition of the diode voltage about 400 kV, beam current about 38 kA, the radiated microwave power is about 1.0 GW, the pulse duration is about 85 ns. Moreover, the radiated microwave power and the pulse duration decline little by little when the shot numbers increase gradually. The experimental results show that the impedance matching is a vital factor for HPM systems and one of the major technical challenges is to improve the cathode for the repetition rate operation MILO.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1063/1.4876599 | DOI Listing |
ESC Heart Fail
September 2025
Division of Heart Failure and Transplant, Mayo Clinic in Florida, Jacksonville, Florida, USA.
Background: Patients with end-stage heart failure and chronic kidney disease requiring dual-organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi-organ failure. Given the limited options available for long-term support in this patient population, there remains a critical need for alternative strategies to optimize end-organ function and bridge patients safely to transplant. With prolonged waitlist times for DOT, we present our experience with the Impella 5.
View Article and Find Full Text PDFInt Forum Allergy Rhinol
September 2025
Department of Otolaryngology-Head and Neck Surgery, Al-Jahra Hospital, Al-Jahra, Kuwait.
Background: Various interventions have been proposed to enhance surgical field quality during endoscopic sinus surgery (ESS). This study evaluates whether preoperative oral clonidine enhances surgical field quality during ESS.
Methods: PubMed, Scopus, Web of Science, Embase, and CENTRAL databases were searched.
Rev Sci Instrum
September 2025
HUN-REN Centre for Energy Research, Budapest, Hungary.
A novel medium-current (up to 20 mA), low normalized beam emittance (<1 π mm mrad) electron cyclotron resonance microwave H+ ion source has been developed at the Center for Energy Research in Budapest, Hungary. This high-stability design targets an energy ripple below 1% while delivering a continuous or pulsed proton beam with adjustable pulse duration (0.1-10 ms) and frequency (0.
View Article and Find Full Text PDFFront Vet Sci
August 2025
Department of Veterinary Medicine, Faculty of Animal Sciences and Food Engineering (FZEA), University of Sao Paulo (USP), Pirassununga, SP, Brazil.
Objective: This study aimed to compare the sedation quality and cardiorespiratory and behavioral effects of detomidine administered intravenously, either in intermittent boluses or as a continuous rate infusion, with butorphanol in horses pre-medicated with acepromazine for odontoplasty procedures.
Methods: A prospective clinical study was conducted with fifteen adult horses randomly assigned to two groups: Bolus group (BG, = 7) and Infusion group (IG, = 8). Both groups received acepromazine premedication, followed by detomidine administration (bolus or infusion).
Front Vet Sci
August 2025
Royal Veterinary College (RVC), London, United Kingdom.
A retrospective analysis of dogs undergoing balloon valvuloplasty of the pulmonic valve between April 2014 and March 2023 was performed. Anaesthetic records from 44 dogs were included in the analysis. Dogs were grouped according to anaesthetic maintenance agent used, inhalational agent with partial intravenous anaesthesia (PIVA, = 31) or propofol total intravenous anaesthesia (TIVA, = 13).
View Article and Find Full Text PDF